Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
about
Optimal Modality for Detecting Distant Metastasis in Primary Nasopharyngeal Carcinoma during Initial Staging: A Systemic Review and Meta-analysis of 1774 PatientsImaging in head and neck squamous cell carcinoma: the potential role of PET/MRI.MR imaging prediction of local control of nasopharyngeal carcinoma treated with radiation therapy and chemotherapyMeta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.Efficiency of ferritin as an MRI reporter gene in NPC cells is enhanced by iron supplementationFactors associated with nodal metastasis in nasopharyngeal cancer: an approach to reduce the radiation field in selected patients.Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysisPET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge.Comparison of positron emission tomography/computed tomography imaging and ultrasound in surveillance of head and neck cancer - The 3-year experience of the ENT Department in Poznan.Comparison of MRI, CT and 18F-FDG PET/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies.Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma.Current treatment options for recurrent nasopharyngeal cancer.Reirradiation for recurrent head and neck cancer.Refractory nasopharyngeal carcinoma: positron emission tomography combined with computed tomography-guided 125I seed implantation therapy after repeated traditional radiochemotherapy.Initial experience of MR/PET in a clinical cancer center.Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.Surgical management of radiation-induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: report of 14 cases.Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.Intravoxel incoherent motion MRI in differentiation between recurrent carcinoma and postchemoradiation fibrosis of the skull base in patients with nasopharyngeal carcinoma.Combined multimodal co-registration of PET/CT and MRI images increases diagnostic accuracy in squamous cell carcinoma staging.Feasibility of simultaneous PET/MR imaging in the head and upper neck area.Magnetic resonance imaging of nasopharyngeal carcinoma
P2860
Q33776738-ED0727E0-B8F7-4D02-8556-210248743F9AQ33792289-B4FE4974-A25C-416E-8308-6FA44173A290Q33823256-B57ECF72-3CE3-4400-9371-68C353C8B144Q34568192-BF52BAC3-AA2A-4396-96DE-1834F34854B5Q35732890-AFD77162-D86A-4C25-82A3-9C11682430A2Q35878493-0D8B583F-1C3C-4D06-A0E2-640C01682284Q36325337-8CEDCBE8-9BD4-4BBB-BD2B-E747FF8E91C6Q36380707-0D2E9F7E-B344-4B74-B7BF-685DB2663C65Q36491659-E517067F-E376-4AD9-8BFC-A5C6AE6B5072Q37248002-AA503980-F0EB-4E97-9E03-A23F9824A80CQ37392480-36842FFB-5353-48BE-B149-AEF72F4069EDQ37448039-F5AEF359-34B6-40C6-A1D1-2964CBF88BABQ37738097-E5F538E1-6BA5-4D6D-9244-9CFBA8E287D2Q37791861-E90B804C-BAD6-4CA0-B3C3-5784EC234514Q38055496-6DBD1951-A759-41D5-8120-F6CA358CF7EBQ38110174-6250250A-7A0D-4253-9AFF-4E34303F3569Q38134357-8EEA73BE-E4BA-46AC-A895-C5618AAEEBBEQ38617866-2CB51663-0714-44F8-8CC3-050412BB0B88Q45367926-D7658784-9ADC-4F2D-82DB-26AB1C00E164Q45906641-D39831A8-601B-4209-969C-15A350B80899Q47124202-1E6CB443-2C6A-4104-9037-738C2A0B0848Q51155388-8A990477-CAA0-4827-B2AD-5A7753956E56Q52982731-94908C74-1D26-489A-8893-3257476A1C40Q52985766-ED71567B-668B-45EE-BDA8-1AE4621448C3Q53245190-712E19DA-741B-4E3F-AD66-F37F84338165Q58876665-A52B68B8-AF94-433D-AD01-1C04609399F2
P2860
Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Detection and restaging of res ...... of MR imaging and FDG PET/CT.
@en
Detection and restaging of res ...... of MR imaging and FDG PET/CT.
@nl
type
label
Detection and restaging of res ...... of MR imaging and FDG PET/CT.
@en
Detection and restaging of res ...... of MR imaging and FDG PET/CT.
@nl
prefLabel
Detection and restaging of res ...... of MR imaging and FDG PET/CT.
@en
Detection and restaging of res ...... of MR imaging and FDG PET/CT.
@nl
P2093
P1433
P1476
Detection and restaging of res ...... of MR imaging and FDG PET/CT.
@en
P2093
Eugenio Borsatti
Giovanni Franchin
Luca Balestreri
Marino Cimitan
Maurizio Comoretto
Mauro Lise
P304
P356
10.1148/RADIOL.2491071753
P407
P577
2008-08-18T00:00:00Z